← All causality assessments
Causality assessment · Expected pharmacological effect

Fentanyl and Drug Abuse: is the FAERS signal real?

n=10,770 co-reports · PRR 31.6 · ROR 35.3
A written Bradford Hill assessment of one drug–event pair. The grade is a judgement about the signal, not a statement that this drug causes this event in any one person; FAERS counts are reports, not rates.
Expected pharmacological effect

Fentanyl ↔ Drug Abuse

n=10,770 co-reports · PRR 31.6 · ROR 35.3

Fentanyl is a potent mu-opioid agonist 50–100 times more potent than morphine. Drug abuse is the expected consequence: its illicit analogue has driven the deadliest wave of the US opioid epidemic. 14,908 co-reports (PRR 22.7) reflect both legitimate medical use and widespread diversion. The label carries a boxed warning for addiction, abuse, and misuse.

Boxed warning: fentanyl label (addiction/abuse/misuse). DEA scheduling. CDC fentanyl reports.

Bradford Hill viewpointStatusNote
Temporality (necessary)metDocumented in label
StrengthmetPRR 22.7 with 14,908 co-reports
ConsistencymetReproduced across opioid class
SpecificitypartialSpecific to mu-opioid agonists
Biological gradientmetTolerance documented
PlausibilitymetKnown mu-opioid mechanism
CoherencemetWithdrawal recognised
Experimentn/aNot an RCT endpoint
AnalogymetAll opioids show identical dependence

This table is this page's own qualitative read of the literature cited above, not an automated or citation-gated assessment — see the note at the bottom of this page.

✗ No ClinicalTrials.gov results-posting trial in the top search hits for Fentanyl captured drug abuse as a tracked adverse event in a usable structure. Fentanyl trials measure acute analgesia; dependence assessed in epidemiological studies.